5th EUROD Winter Meeting - fully virtual!

The 5th EUROD Winter Meeting is just around the corner - it will be a Fully Virtual Event, and you can still Register for Free!

On the 20th and 21st of January, the EUROD initiative will be online with a fully virtual edition of the 5th Winter Meeting! This year's CME is titled "Controversies in renal osteodystrophy: focus on adynamic bone (disease)" and will feature a mix of lectures and novel research presentations over the course of two afternoons. 

Register for free at My ERA!

***Updated program***

5th EUROD winter meeting 2022 – FULLY VIRTUAL

14:00 – 18:00: 5TH EUROD WINTER MEETING 2022

14:00 – 14:10: Welcome and introduction to the program
(P. Evenepoel, Leuven, Belgium)
 

14:10 – 16:15: Research Forum Part 1

Chairs: P.D’Haese & J.Bacchetta

14:10–14:30 (ML): Klotho in skeletal pathobiology (H. Komaba, Tokai, Japan)

14:30–14:50 (ML): Klotho in vascular pathobiology (R. Mencke, Groningen, The Netherlands)

14:50–15:10 (FC): sKlotho as a biomarker of vascular and bone damage in moderate chronic renal failure (J Martín-Vírgalas, Oviedo, Spain)

15:10–15:30 (FC): MicroRNA-145 and microRNA-486 regulate vascular smooth muscle cells osteogenic differentiation (S Fernández-Villabrille, Oviedo, Spain)

15:30–15:50 (ML):Vascular calcification impairs bone metabolism
(M. Mace, Copenhagen, Denmark)

15:50–16:10: Effects of androgen replacement therapy on bone and vascular complications in an adenine-induced CKD rat model (K David, Leuven, Belgium)

16:15 – 16:45: Catch up and break

*****

CME: Controversies in renal osteodystrophy: focus on adynamic bone (disease)

16:45 – 18:00: Part 1 Pathophysiological aspects

Chairs: S.Mazzaferro &J.Cannata-Andia

16:45 – 17:15: Parathyroid hormone biology and signaling
(D. Hansen, Herlev, Denmark)

17:15 – 17:45: Adynamic bone disease, a conceptual and diagnostic challenge
(M. Haarhaus, Stockholm, Sweden)

 

17:45 18:00: Closing remarks (P.Evenepoel, Leuven, Belgium)

*****

Friday Jan 21, 2022

14:00 – 14:15: Welcome and introduction to the program

(P.Evenepoel, Leuven, Belgium)

 

CME: Controversies in renal osteodystrophy: focus on adynamic bone (disease)

14:15 – 16:00: Part 2: Therapeutic challenges

Chairs:  MH. Lafage-Proust & M.Haarhaus

 

14:15–14:30: Antiresorptive agents in advanced CKD: pro

(B. Abrahamsen, Odense, Denmark/Oxford, UK)

14:30–14:45: Antiresorptive agents in advanced CKD: con

(M. Cohen-Solal, Paris, France)

14:4515:00: Panel discussion and Q&A
 

15:00–15:15: PTH analogs in early stage CKD (M. Pazianas, Oxford, UK)

15:15–15:30: PTH analogs in advanced stage CKD (S. Mazzaferro, Rome, Italy)

15:30–15:45: Romosozumab: potentials and pit-falls in CKD (R. de Jongh, Amsterdam, The Netherlands)

15:4516:00: Panel discussion and Q&A

*****

16:00 – 18:00: Research Forum Part 2

Chairs: A.Ferreira & G.Spasovski

16:00–16:20 (ML): Added value of bone histomorphometry post-transplant for the assessment of long-term skeletal health (N. Bravenboer, Amsterdam, The NL)

16:20–16:40 (FC): Study of bone strength measured in vivo by impact microindentation in the peri-renal transplantationperiod (MJ Lloret Cora, Barcelona, Spain)

16:40–17:00 (FC):A 3D in vitro model of impaired osteocytes activity under exposure to indoxyl sulfate (S. Mihaila, Utrecht, The Netherlands)

17:00–17:20 (FC): Bone secondary mineralization, osteocyte expression of SIBLINGs and sclerostin are conditioned by the different types of renal osteodystrophy
(MJ Begin, Quebec, Canada)

17:20–17:40 (ML): Mg in bone and vascular health: time to act?
(I Bressendorf, Hillerod, Denmark)

17:40–17:45 (P): Mg in dialysate: a call for a pragmatic study (G. Meeus, Kortrijk, Belgium)

 

17:4518:00: Best Abstract Award and Closing Remarks
(P. Evenepoel, Leuven, BE)